Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progression
Abstract Background The prognosis of patients with lung cancer accompanied by interstitial pneumonia is poorer than that of patients with lung cancer but without interstitial pneumonia. Moreover, the available therapeutic interventions for lung cancer patients with interstitial pneumonia are limited...
Main Authors: | Kiyofumi Shimoji, Taku Nakashima, Takeshi Masuda, Masashi Namba, Shinjiro Sakamoto, Kakuhiro Yamaguchi, Yasushi Horimasu, Takahiro Mimae, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Morihito Okada, Noboru Hattori |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-11-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-023-04756-6 |
Similar Items
-
Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal Transition
by: Kentaro Tokumo, et al.
Published: (2023-02-01) -
Nestin and Notch3 collaboratively regulate angiogenesis, collagen production, and endothelial–mesenchymal transition in lung endothelial cells
by: Wakako Daido, et al.
Published: (2023-09-01) -
High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis
by: Takeshi Masuda, et al.
Published: (2024-02-01) -
Correlations of forced oscillometric bronchodilator response with airway inflammation and disease duration in asthma
by: Naoko Higaki, et al.
Published: (2021-01-01) -
Preserved ratio impaired spirometry with or without restrictive spirometric abnormality
by: Shinichiro Miura, et al.
Published: (2023-02-01)